LACTOSE (INDIA)
|
|
BOM : 524202     NSE :      | |
LT :  
    Long Term Analysis
Fundamentals : Bad
Valuation : Bad [Stock is Expensive] Debt : High |
Updated: |
ST :  
    Short Term Analysis
Quarterly Earnings Trend : Neutral
Price Momentum : Downward Pledged Shares : NA |
Oct 07,2024 |
Price(EOD): ₹ 149.60
This is the End-of-Day (EOD) Stock Price updated daily by 7 pm IST.
|
Pharmaceuticals & Drugs |
MCap: ₹ 188.50 Cr |
Industry Peers & Returns | 1W | 1M | 1Y |
LACTOSE (INDIA) | -1.8% | -6.7% | 133.5% |
SUN PHARMACEUTICAL INDUSTRIES | -1.1% | 4.4% | 67.3% |
CIPLA | -1.8% | -0.2% | 37.2% |
DR REDDYS LABORATORIES | -2.3% | -1.4% | 21.5% |
ZYDUS LIFESCIENCES | -1.6% | -5.8% | 73.2% |
DIVIS LABORATORIES | -0.8% | 5.4% | 45.7% |
FUNDAMENTAL ANALYSIS OF LACTOSE (INDIA)
 Y : Last Audited Annual/Yearly Data
TTM i.e. Trailing Twelve Months is calculated using last 4 quarterly data and is a good substitute to track last 4 Qtr Annual result before the subsequent year data is published and audited.
Learn More
VALUATION OF LACTOSE (INDIA)
 Ratio | Standalone | |
---|---|---|
P/E P/B P/S |
23.24
P/E Calculated based on Trailing Twelve Months (TTM) Earnings of Rs 8.10 Cr
[Latest Qtr - Jun2024 - Standalone Results ] 4
P/B Calculated based on Book Value of Rs 47.10 Cr
[Latest Year - Mar2024 - Standalone Results ] 1.63
P/S Calculated based on Trailing Twelve Months (TTM) Revenues of Rs 0.00 Cr
[Latest Qtr - Jun2024 - Standalone Results ] |
|
Financial Ratios → |
Model | Discount(-)/ Premium(+) |
---|---|
EV/EBIDTA EV/Sales Price/Sales |
174% -12% 43% |
SHARE PRICE MOMENTUM OF LACTOSE (INDIA)
LACTOSE (INDIA) vs SENSEX
DEBT OF LACTOSE (INDIA)
Year | Debt/Equity ratio | |
---|---|---|
Standalone | Consolidated | |
2023 2022 2021 Avg_3yrs |
0.96 1.06 1.34 1.12 |
- - - - |
[Last Annual Data : Mar2023]
|
||
Financial Ratios → |
PLEDGED PROMOTER SHARES OF LACTOSE (INDIA)
Pledged Promoter Shares |
NA | |
---|---|---|
If less than 25% | Good |
|
If between 25% and 50% | Neutral | |
If greater than 50% | Bad | |
Shareholding Pattern → |
QTRLY RESULTS OF LACTOSE (INDIA)
Standalone | Q-o-Q | Y-o-Y |
---|---|---|
Revenue Op Profit Profit Before Tax Profit After Tax |
0.22% -8.81% -10.88% -5.38% |
7.27% 47.81% 146.98% 137.1% |
QtrlyTrend |
2 | |
Latest Qtr: Jun2024 | ||
Quarterly Result Analysis → |
LACTOSE (INDIA) related INDICES
You may also like the below Video Courses
FAQ about LACTOSE (INDIA)
Is LACTOSE (INDIA) good for long term investment?
As on Oct 07,2024, the Fundamentals of LACTOSE (INDIA) look Poor and hence it may not be good for long term investment ! See Financial Performance of LACTOSE (INDIA) . Please look at the other parameters such as Valuation, Price Momentum, News & Corporate Governance and/or consult an Investment Advisor before taking an investment decision!Is LACTOSE (INDIA) UnderValued or OverValued?
As on Oct 07,2024, LACTOSE (INDIA) is Over Valued based on the estimates of intrinsic value and hence may not be a good buying opportunity according to Share Valuation at this time!What is the Intrinsic Value of LACTOSE (INDIA) ?
As on Oct 07,2024, the Intrinsic Value of LACTOSE (INDIA) is Rs. 104.48 estimated based on Median of the 3 historical models.Fair Value [Median EV / EBIDTA Model] : Rs. 54.68
Fair Value [Median EV / Sales Model] : Rs. 169.71
Fair Value [Median Price / Sales Model] : Rs. 104.48
Estimated Median Fair Value of LACTOSE (INDIA) : Rs. 104.48
The fair value of any stock is always subjective and should, in no way, be taken as a recommendation to buy/sell the same.